Ambrx Biopharma Inc.

CIK 1836056 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ambrx Biopharma Inc..

Recent SEC filings

FiledFormAccession number
Mar 7, 202425-NSE0001354457-24-000130
Feb 9, 2024SC 13G/A0001193125-24-030277
Oct 23, 202315-12G0001193125-23-260905
Oct 12, 20238-K0001193125-23-254549
Oct 12, 202325-NSE0001354457-23-000765
Oct 12, 2023S-8 POS0001193125-23-255002
Oct 12, 2023S-8 POS0001193125-23-254983
Oct 12, 2023S-8 POS0001193125-23-255011
Oct 12, 2023S-8 POS0001193125-23-255027
Oct 10, 20238-K0001193125-23-253527
Oct 10, 2023SC 13G0001140361-23-047537
Oct 6, 20238-K0000950170-23-052396
Sep 25, 2023SC 13G0001104659-23-103570
Sep 25, 20238-K0000950170-23-049468
Sep 19, 202340000929638-23-002564
Sep 15, 20238-K0001193125-23-236202
Sep 15, 2023DEFM14A0001193125-23-236205
Sep 6, 202340000950170-23-046801
Sep 6, 202330000950170-23-046800
Sep 6, 20238-K0000950170-23-046718
Aug 25, 20238-K0000950170-23-044643
Aug 9, 202310-Q0000950170-23-040568
Jul 7, 202340000950170-23-032230
Jul 7, 202340000950170-23-032232
Jul 7, 202340000950170-23-032229